Prevention of host-to-host transmission by SARS-CoV-2 vaccines

D Mostaghimi, CN Valdez, HT Larson… - The Lancet infectious …, 2022 - thelancet.com
As the number of individuals vaccinated against SARS-CoV-2 rises worldwide, population-
level data regarding the vaccines' ability to reduce infection are being generated …

Instructing durable humoral immunity for COVID-19 and other vaccinable diseases

D Bhattacharya - Immunity, 2022 - cell.com
Many aspects of SARS-CoV-2 have fully conformed with the principles established by
decades of viral immunology research, ultimately leading to the crowning achievement of …

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals

K Sano, D Bhavsar, G Singh, D Floda… - Nature …, 2022 - nature.com
Immune responses at the respiratory mucosal interface are critical to prevent respiratory
infections but it is unclear to what extent antigen specific mucosal secretory IgA (SIgA) …

Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent …

S Sheikh-Mohamed, B Isho, GYC Chao, M Zuo… - Mucosal …, 2022 - nature.com
Although SARS-CoV-2 infects the upper respiratory tract, we know little about the amount,
type, and kinetics of antibodies (Ab) generated in the oral cavity in response to COVID-19 …

Immunity to enteric viruses

A Lockhart, D Mucida, R Parsa - Immunity, 2022 - cell.com
Pathogenic enteric viruses are a major cause of morbidity and mortality, particularly among
children in developing countries. The host response to enteric viruses occurs primarily within …

Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS‐CoV‐2 infection

S Sheikh‐Mohamed, EC Sanders… - Immunological …, 2022 - Wiley Online Library
In early 2020, a global emergency was upon us in the form of the coronavirus disease 2019
(COVID‐19) pandemic. While horrific in its health, social and economic devastation, one …

COVID‐19: Clinical status of vaccine development to date

S Kumar, M Basu, P Ghosh, A Ansari… - British Journal of …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)‐induced COVID‐19 is a
complicated disease. Clinicians are continuously facing difficulties to treat infected patients …

[HTML][HTML] Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV

VA Matveev, EZ Mihelic, E Benko, P Budylowski… - Iscience, 2023 - cell.com
Older individuals and people with HIV (PWH) were prioritized for COVID-19 vaccination, yet
comprehensive studies of the immunogenicity of these vaccines and their effects on HIV …

Efficient mucosal antibody response to SARS-CoV-2 vaccination is induced in previously infected individuals

K Sano, D Bhavsar, G Singh, D Floda, K Srivastava… - MedRxiv, 2021 - medrxiv.org
Mucosal immune responses are critical to prevent respiratory infections but it is unclear to
what extent antigen specific mucosal secretory IgA (SIgA) antibodies are induced by mRNA …

Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B. 1.1. 529 …

JW Xu, BS Wang, P Gao, HT Huang… - Emerging Microbes & …, 2024 - Taylor & Francis
Vaccination strategies that can induce a broad spectrum immune response are important to
enhance protection against SARS-CoV-2 variants. We conducted a randomized, double …